CXCL13 and myeloid sarcoma: Indeed, a meta-analysis on 226 studies, including more than 13,000 patients with MS, clearly showed that TNF-α, CXCL8, CXCL13, IL-15, and IL12-p40 are increased in the CSF of MS compared to controls [29].